Emily McDowell

Title: Emily McDowell: Innovator in Blood Cell Lysis Compositions

Introduction

Emily McDowell is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of blood cell lysis compositions. Her innovative work has the potential to enhance various medical applications.

Latest Patents

Emily McDowell holds a patent for "Blood cell lysis compositions and uses thereof." This patent describes a blood cell lysis composition that includes a buffer and a secondary alcohol ethoxylate at a concentration ranging from about 2.5 percent to about 20% weight per volume. The secondary alcohol ethoxylate may include Tergitol™ TMN-100X or Tergitol™ 15-S-9. The composition is designed to lyse at least 90% of blood cells in a blood sample, showcasing its effectiveness in medical diagnostics.

Career Highlights

Emily is currently employed at Instrumentation Laboratory Company, where she continues to innovate and develop new technologies. Her work is instrumental in advancing the capabilities of medical devices and improving patient outcomes.

Collaborations

Emily has collaborated with notable colleagues, including Miklos Erdosy and Hyoungsik Yim. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Emily McDowell is a trailblazer in the field of blood cell lysis compositions, with her patent reflecting her commitment to innovation in medical technology. Her contributions are paving the way for advancements in healthcare and diagnostics.